Claim your company profile
AfterRaise/Today/26 October 2026

AfterRaise daily

26 October 2026 on AfterRaise

13 companies raised $1.8B in disclosed rounds of $5M or more. Every figure links to its source, and every company page follows what happens next.

13companies raised yesterday LiveNew+19% vs 7-day average57raised in the last 7 days Live-33% vs last week21US expansion signals this month AfterRaise intelligence24companies stated hiring plans this month AfterRaise intelligence1972open roles Public signal
FundingPublic signal2 days ago
Flapping Airplanes
$1.0B · Series A · San Francisco, USA · Semiconductors & Hardware
What changed

Raised $1.0B in Series A funding, led by Index Ventures and Lux Capital.

The company said the funding supports accelerate its core machine learning research pipelines, expand its deep-tech engineering workforce, scale its software infrastructure testing, and commercialize its custom operational software stack.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceHardware engineeringIndustrial partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Pathos AI
$237M · Series E · NYC, USA · Biotech & Pharma
What changed

Raised $237M in Series E funding, led by Bristol Myers Squibb (NYSE: BMY).

The company said the funding supports further scale its platform's capabilities and accelerate the clinical development of its AI-steered portfolio, including advancing JSKN016 toward registrational studies and driving the clinical advancement of pocenbrodib, AZD4241, and DO-2.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringResearch programme expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Star Therapeutics
$200M · Undisclosed · San Francisco, USA · Biotech & Pharma
What changed

Raised $200M, led by OrbiMed and Janus Henderson Investors.

The company said the funding supports support its pipeline of therapies and advance its current preclinical programs into the clinic.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Tractian
$130M · Series D · Atlanta, USA · AI & Data Infrastructure
What changed

Raised $130M in Series D funding, led by Sapphire Ventures and co-led by M&G's Catalyst.

The company said the funding supports scale its platform further, providing manufacturers, data center operators, defense companies, utilities, and more with strategic insights to optimize machine health, close the alert-to-action gap, and eliminate unplanned downtime.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringManufacturing capacity expansion
Where help may be relevant AfterRaise intelligenceInfrastructure and computeSecurity reviewData partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Nevis
$70M · Series B · NYC, USA · Fintech & Insurance
What changed

Raised $70M in Series B funding, led by EQT Ventures.

The company said the funding supports expand agent capabilities, deepen integrations across the custodian and wealthtech ecosystem, and grow its product and go-to-market teams.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceBanking partnershipsEnterprise salesFinance hiringMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Hexagon Bio
$62M · Series C · Menlo Park, USA · Biotech & Pharma
What changed

Raised $62M in Series C funding, led by The Column Group.

The company said the funding supports support the Phase 1 clinical trial of HEX-360 and advance additional payload mechanisms and dual payloads from its proprietary platform.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringResearch programme expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Nirva
$25M · Undisclosed · San Francisco, USA · AI & Data Infrastructure
What changed

Raised $25M.

The company said the funding supports accelerate the production engineering of its consumer hardware devices, optimize its proprietary on-device ambient machine learning models, expand its specialized mechanical design teams, and scale its global go-to-market initiatives.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Nous
$17M · Undisclosed · London, UK · AI & Data Infrastructure
What changed

Raised $17M.

The company said the funding supports expand its automated service architecture into additional household spending categories and regulated insurance verticals, accelerate international market expansion, and integrate advanced features for managing everyday administrative tasks.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
adsilico
£10M · Series A · Leeds, UK · Healthcare & Medtech
What changed

Raised £10M in Series A funding, led by PXN Ventures.

The company said the funding supports extend its work on heart models into devices for the brain (such as flow diverters used to treat brain aneurysms) and grow its team from 14 to 34 people.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringRepeatable go-to-market build
Where help may be relevant AfterRaise intelligenceProvider partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical evidence
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Kivo Health
$10M · Series A · San Francisco, USA · Healthcare & Medtech
What changed

Raised $10M in Series A funding, led by Allumia Ventures.

The company said the funding supports scale its remote clinical network, expand distribution partnerships with commercial health plans and Medicare Advantage providers, accelerate technical platform enhancements, and generate long-term clinical outcome data to prove home-based care efficacy.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical hiringProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
PreScalar
$7M · Seed · San Francisco, USA · Robotics & Manufacturing
What changed

Raised $7M in Seed funding, led by Dynamo Ventures and BMW i Ventures.

The company said the funding supports expand its R&D and manufacturing capabilities, grow its team, and bring its solution to more production environments.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceManufacturing scale-upCertificationFactory operationsEngineering hiringDistribution partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
Sonexos
$6M · Series A · Lausanne, Switzerland · Other
What changed

Raised $6M in Series A funding, led by Valquest Partners.

The company said the funding supports support the transition from engineered prototypes to qualified industrial products, fund customer integration, reliability testing, qualification, and regulatory compliance, expand its engineering and applications teams in Switzerland and internationally, and broaden international protection of its intellectual property.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCommercial leadershipOperations hiringGo-to-market partnershipsFinance and complianceMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal2 days ago
DropGenie
$5M · Seed · Cambridge, USA · Biotech & Pharma
What changed

Raised $5M in Seed funding.

The company said the funding supports accelerate the commercialization of its first product, expand customer engagement models, and expand its global footprint.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.